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Abstract
Aim: To investigate the effect of increases in extracellular Ca
2+ entry pro-
duced by the L-type Ca
2+ channel agonist FPL-64176 (FPL) upon acute atrial
arrhythmogenesis in intact Langendorff-perfused mouse hearts and its
dependence upon diastolic Ca
2+ release from sarcoplasmic reticular Ca
2+
stores.
Methods: Confocal microscope studies of Fluo-3 ﬂuorescence in isolated
atrial myocytes were performed in parallel with electrophysiological exam-
ination of Langendorff-perfused mouse hearts.
Results: Atrial myocytes stimulated at 1 Hz and exposed to FPL (0.1 lm)
initially showed (<10 min) frequent, often multiple, diastolic peaks following
the evoked Ca
2+ transients whose amplitudes remained close to control
values. With continued pacing (>10 min) this reverted to a regular pattern of
evoked transients with increased amplitudes but in which diastolic peaks
were absent. Higher FPL concentrations (1.0 lm) produced sustained and
irregular patterns of cytosolic Ca
2+ activity, independent of pacing. Nifedi-
pine (0.5 lm), and caffeine (1.0 mm) and cyclopiazonic acid (CPA)
(0.15 lm) pre-treatments respectively produced immediate and gradual
reductions in the F/F0 peaks. Such nifedipine and caffeine, or CPA pre-
treatments, abolished, or reduced, the effects of 0.1 and 1.0 lm FPL on
cytosolic Ca
2+ signals. FPL (1.0 lm) increased the incidence of atrial tachy-
cardia and ﬁbrillation in intact Langendorff-perfused hearts without altering
atrial effective refractory periods. These effects were inhibited by nifedipine
and caffeine, and reduced by CPA.
Conclusion: Enhanced extracellular Ca
2+ entry exerts acute atrial ar-
rhythmogenic effects that is nevertheless dependent upon diastolic Ca
2+ re-
lease. These ﬁndings complement reports that associate established, chronic,
atrial arrhythmogenesis with decreased overall inward Ca
2+ current.
Keywords atrial arrhythmogenesis, Ca
2+ homeostasis, calcium entry,
murine hearts, store calcium.
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tained disorders of cardiac rhythm encountered in
clinical practice and result in substantial mortality and
morbidity. For example, atrial ﬁbrillation (AF) is
associated with stroke, thromboembolism, heart failure
and impaired quality of life; treatment strategies have
largely proved inadequate (Thrall et al. 2006). It is
attributed to irregular and rapid atrial electrical activity
due to ectopic activity, single circuit or multiple
wavelets of re-entry throughout the atria (Moe et al.
1964, Nattel 2002).
Persistent atrial arrhythmia appears to lead to
changes in electrical properties of the cardiac tissue.
This electrical remodelling may include alterations in
cellular Ca
2+ homeostasis including overload (Ryu et al.
2005, Yeh et al. 2008). Studies in both animal models
and human atrial cardiomyocytes from patients in
established AF report reduced current densities through
L-type Ca
2+ channels (ICa,L) (Yue et al. 1997, Bosch
et al. 1999, Van Wagoner et al. 1999, Skasa et al. 2001,
Yagi et al. 2002). The balance between inward currents
through L-type Ca
2+ channels (LTCCs) and outward K
+
currents are responsible for the plateau phase that
extends the duration of action potentials in human
cardiomyocytes. They are also responsible for Ca
2+
entry that in turn regulates the contractile force (Fabiato
& Fabiato 1975, Falk 1998). Their inhibition results in
a shortening of both atrial action potential duration and
effective refractory period (Morillo et al. 1995, Wijffels
et al. 1995, Li & Nattel 1997). This in turn favours re-
entry and persistence of the AF condition. Both human
hearts with chronic AF (Christ et al. 2004) and a rabbit
model of rapid atrial pacing (Bosch et al. 2003) showed
parallel reductions in b-2 subunit expression and ICa,L
followed by changes in the a1C subunit mRNA levels.
This supports the concept that reduced a subunit
expression underlies this reduction in voltage-dependent
(ICa,L) despite increased single ICa,L channel open
probability as reported in hearts of patients with
established AF (Klein et al. 2003). Conversely, it is well
established that AF is associated with an abnormal
sarcoplasmic reticular (SR) Ca
2+ release reﬂecting
increased open probabilities in the relevant RyR2
release channels resulting from their hyperphosphory-
lation (Nattel et al. 2007).
However, such earlier studies described results from
models of established AF or chronic AF patients. There
are relatively few reports on the features of acute atrial
arrhythmogenesis that can include either atrial tachy-
cardia (AT) or AF, and the possible involvement of
LTCC activity. Reductions in ICa,L form a characteristic
and pathophysiologically important part of myocardial
remodelling observed during long-lasting AF. However,
recent studies indicate that they are not present in
patients with non-persistent AF (Skasa et al. 2001).
Nevertheless, acute atrial arrhythmias (both ﬁbrillation
and ﬂutter) occur with a 20–50% incidence following
cardiothoracic surgery, particularly coronary artery
bypass grafting. They most frequently occur 2 days
after surgery and are rare after 7–15 postoperative days.
However such episodes are usually short-lived. This
incidence is signiﬁcantly reduced by treatment with b-
blockers and/or Ca
2+ channel antagonists (Podesser
et al. 1995, Yilmaz et al. 1996, Kim et al. 2002,
Dobrilovic et al. 2005, Baker & White 2007, Iwamoto
& Inoue 2007). Conversely, activation of b-adrenergic
signalling leads to threefold to fourfold increases in
calcium current. The latter results from protein kinase A
phosphorylation of calcium channels (Hulme et al.
2006).
The present study accordingly goes on to investigate
the possible roles of altered Ca
2+ homeostasis on the
initiation of acute atrial arrhythmias at both the cellular
and the whole organ levels in intact murine hearts,
through enhancing ICa,L. Murine hearts were used in
view of their potential utility in future atrial studies of
the effects of genetic modiﬁcations. Despite inevitable
differences from human hearts, such genetically modi-
ﬁed models have been successfully used to model
mechanisms of ventricular arrhythmogenesis in LQTS3
(Thomas et al. 2008), Brugada syndrome (Stokoe et al.
2007) and catecholaminergic polymorphic ventricular
tachycardia (Priori et al. 2001, Cerrone et al. 2005,
Goddard et al. 2008). We provide experimental evi-
dence that enhanced ICa,L-mediated extracellular Ca
2+
entry exerts acute atrial arrhythmogenic effects that
nevertheless depend upon diastolic release of intracel-
lularly stored SR Ca
2+. We compared the effects of
FPL-64176 (methyl 2,5-dimethyl-4-[2-(phenylmethyl)
benzoyl]-1H-pyrrole-3-carboxylate; FPL) on regularly
stimulated isolated murine atrial myocytes and atrial
arrhythmogenesis in isolated Langendorff-perfused
murine hearts. FPL is known to prolong opening of
single LTCCs during depolarization and slow channel
closing upon repolarization (Rampe & Lacerda 1991,
Baxter et al. 1993, Lauven et al. 1999, Fan et al. 2000).
FPL was used both alone and in combination with three
agents with known effects upon cellular Ca
2+ homeo-
stasis. Of these, nifedipine acts as a competitive LTCC
blocker (Triggle 2003) inhibiting inward Ca
2+ current
(Shen et al. 2000, Thomas et al. 2007). Caffeine is
thought to increase the release of intracellularly stored
Ca
2+, thereby ultimately depleting such stores, whether
by sensitizing cardiac SR Ca
2+ release-ryanodine recep-
tors (RyR2s) to cytosolic Ca
2+ or inhibiting phospho-
diesterase activity, thereby increasing cellular cyclic
adenosine monophosphate (cAMP) (Daly 2007). Final-
ly, cyclopiazonic acid (CPA), is known to inhibit SR
Ca
2+-ATPase activity (Seidler et al. 1989, Du et al.
1996) by blocking its Ca
2+ access channel (Moncoq
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levels of SR Ca.
Materials and methods
Inbred male and female 129/Sv wild-type mice (Harlan,
Bicester, UK) kept in an animal house at room
temperature were subjected to 12 h light–dark cycles,
and fed sterile rodent chow with constant access to
water. All procedures conformed to the U.K. Animals
(Scientiﬁc Procedures) Act (1986). The following solu-
tions were used in the course of the study: Solution A
was prepared for electrophysiological experiments on
Langendorff-perfused hearts. It consisted of normal
bicarbonate-buffered Krebs-Henseleit (KH) solution
containing (in mm): 119 NaCl, 25 NaHCO3, 4.0
KCl, 1.2 KH2PO4, 1.0 MgCl2, 1.8 CaCl2, 10 glucose
and 2.0 sodium pyruvate, and at pH 7.4 maintained by
bubbling with 95% O2–5% CO2 (British Oxygen,
Manchester, UK). Solution B was the basic stock
solution from which other solutions (C-H) used in
myocyte isolation were derived (in mm): 125 NaCl,
4.75 KCl, 1.2 MgSO4, 1.2 KH2PO4, 30 4-(2-hydroxy-
ethyl)-1-piperazineethanesulphonic acid (Hepes), 10
glucose, 50 taurine and titrated to pH 7.4 with NaOH.
It was ﬁltered with a 0.2 lm ﬁlter (Millipore, Billerica,
MA, USA) to remove microbes and small particles.
Solution C: 750 lm Ca
2+-containing perfusion solution
was prepared by further adding 750 lm CaCl2. Solu-
tion D: Ca
2+-free nitrilotriacetic acid (NTA)-containing
solution was prepared adding 5 mm NTA to solution
B, and titrating the resulting solution to pH 6.95 with
NaOH. Solution E: Enzyme solution was prepared by
adding 1.5 mg mL
)1 collagenase (Worthington Type
II), 2.0 mg mL
)1 hyaluronidase (Sigma, Gillingham
Dorset, UK), and 100 lm CaCl2 to solution B. Solution
F: a further digestion buffer made by adding
1.0 mg mL
)1 collagenase and 1.0 mg mL
)1 BSA to
solution B. Solution G: Enzyme washout solution was
made by adding 1.0 mg mL
)1 BSA and 250 lm CaCl2
to solution B. Solution H: Ca
2+-containing solution
was made by adding 1.2 mm CaCl2 to solution B. After
preparation, solutions D, E, F and G were always
ﬁltered using a 0.2 lm ﬁlter to remove microbes and
small particles.
Measurement of cytosolic Ca
2+ transients
Mice, aged 10–12 weeks at which viable atrial myocyte
isolation could most readily be accomplished, were
killed by cervical dislocation. A total of nine mice were
used. Hearts were rapidly excised and cannulated in
ice-cold KH solution (solution A). They were then
mounted onto a Langendorff perfusion system and
successively perfused with solution C (for 4 min),
solution D (4 min) and solution E (10–12 min) at
37  C. The heart was then removed from the perfusion
apparatus. The atrial appendages were then excised
and chopped into several pieces in solution F. These
were further incubated for another 5–10 min with
gentle manual agitation using a 1 mL tip transfer
pipette. All these latter steps were performed at 36–
37  C. Cells were then separated from the enzymic
solution by centrifuging at 243 g for 3 min. The
resulting isolated cells were then washed using solution
G followed after 5 min, by centrifugation at 30 g for
2 min. The cells were then resuspended in solution H
and after a 5 min interval, centrifuged again at 30 g for
2 min. The cells were then maintained at room
temperature in solution H for the experiments that
followed. The cells were then placed on a grade 1
circular laminin-coated coverslip (Menzel, Glasbear-
beitungswerk, Germany) that formed the ﬂoor of a
1.5 mL perfusion chamber to which it was ﬁxed with
vacuum grease. They were then loaded with the
acetoxymethyl (AM) ester of Fluo-3 (Molecular Probes,
Leiden, The Netherlands) by incubation with 5 lm
Fluo-3 AM in solution H (1.2 mm CaCl2) for 10–
20 min in the dark before washout of the Fluo-3
containing solution. They were then transferred onto
the stage of a Zeiss LSM-510 laser scanning confocal
system (Zeiss, Oberkochen, Germany) with a ·20 air
objective on a Zeiss Axiovert 100 M inverted micro-
scope. Fluo-3 ﬂuorescence emission was excited with a
488 nm argon laser and measured at wavelengths
between 505 and 550 nm. Images were then analysed
using in-house custom-made software. Series of 500
frames (128 · 64 pixels per frame) were collected at a
scanning frequency of 25 ms per frame to monitor
ﬂuorescence changes over time. Fluorescence (F) mea-
surements were corrected for background signal in
regions outside the cells. They were made within
deﬁned regions of interest (ROI; F) and were normal-
ized to their baseline ﬂuorescence (F0) values. For each
of the myocytes studied, peak F/F0 values were
calculated throughout each time series acquired. This
typically contained around 12–13 peaks from which
the mean peak F/F0 could be obtained. A mean peak F/
F0 was then calculated for that series. Cells were paced
at 1 Hz (5 V above excitation threshold of 30–60 V for
2 ms) with two ﬁeld electrodes. All ﬂuorescence studies
were carried out at room temperature. Ca
2+ transients
were measured from ROIs covering entire cells.
Atrial electrophysiological experiments
Male and female mice (age 3–6 months), at which their
aortic size permitted reproducible in situ cannulation,
were randomly selected, heparinized with 50 IU
heparin (IP) 10–15 min before being killed by cervical
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Act 1986). A total of 72 mice were used. The heart was
cannulated in situ using a straight-cut and smoothed 21-
gauge needle previously ﬁlled with solution A, dissected
and then ﬁxed securely with a straight 60 g pressure
micro-aneurysm clip (Harvard Apparatus, Edenbridge,
UK). The cannulated heart was perfused with solution A
at room temperature and then mounted onto a Lange-
ndorff system (Balasubramaniam et al. 2004) then
perfused at a constant ﬂow rate of 2–2.5 mL min
)1
(Watson-Marlow Bredel Peristaltic pumps, model 505S;
Falmouth, Cornwall, UK) with solution A. The perfus-
ate was ﬁrst ﬁltered through 200 lm and 5 lm mem-
branes (Millipore UK, Watford, UK), and warmed to
37  C by a water-jacketed heat exchange coil (Model C-
58A; Techne, Cambridge, UK) before entering the
coronary arterial network. Viable hearts regained a
pink appearance and spontaneous rhythmic contrac-
tions upon warming. The hearts were perfused retro-
gradely for not less than 10 min in the absence of
stimulation. Experiments were only performed in intact
Langendorff preparations showing clear-cut 1 : 1 atrio-
ventricular (AV) conduction during the intrinsic activity
following cannulation.
The electrophysiological studies involved compari-
sons of records from simultaneous recordings made at
two sites. Thus, in addition to the paired platinum-
stimulating electrodes placed on the right atrium, two
bipolar recording electrodes of 1 mm interpole spacing
were placed on the left atrium and left ventricle
respectively. Hearts were initially paced for not less
than 5 min at 10 Hz to permit them to regain their
physiological steady state. Three types of pacing proto-
cols were then used. First, hearts were studied at their
intrinsic rates in the absence of stimulation. Second,
hearts were subject to regular pacing at 10 Hz using
2 ms square-wave stimuli set at two times the excitation
threshold (Grass S48 stimulator; Grass-Telefactor,
Slough, UK). Third, hearts were studied using a
programmed electrical stimulation (PES) procedure
adopted from clinical techniques previously used in
ventricular studies (Saumarez & Grace 2000, Balasubr-
amaniam et al. 2004) but recently introduced in clinical
studies of atrial electrophysiology (Wellens 2003,
Brembilla-Perrot et al. 2005). These began using stan-
dard baseline pacing stimuli at a frequency of 10 Hz for
20 s. Drive trains of eight paced beats (S1) were each
followed by an extra stimulus (S2) every ninth beat,
initially at an S1–S2 interval equal to the pacing
interval. Each subsequent cycle reduced the S1–S2
interval by 1 ms until atrial refractoriness was reached.
The resulting electrogram signals were ampliﬁed, band-
pass ﬁltered (30 Hz to 1 kHz; Gould 2400S; Gould-
Nicolet Technologies, Ilford, Essex, UK) and digitized
at a sampling frequency of 5 kHz (Spike2 software;
CED1401plus; Cambridge Electronic Design, Cam-
bridge, UK). The present protocols thus differed from
our previous studies on ventricular arrhythmogenesis
(Balasubramaniam et al. 2004, Stokoe et al. 2007,
Thomas et al. 2008) in pacing hearts from the atria
rather than the ventricles. Furthermore, use of the
previous 8 Hz pacing rate permitted atrial escape
phenomena that precluded regular activation by the
stimulus train. Accordingly we used a higher pacing rate
of 10 Hz to ensure regular atrial stimulation under all
the pharmacological conditions. In some hearts, this
resulted in a gradual development of an AV block.
Nevertheless, withdrawal of the regular pacing permit-
ting resumption of normal intrinsic activity led to
restoration of normal 1 : 1 AV conduction once phar-
macological agents were withdrawn. These ﬁndings
likely relate to AV node refractoriness at high pacing
rates: we observed that the atria had shorter refractory
periods (24  7 ms, n = 33) than the AV node
(61  12 ms, n = 5).
Statistical analysis
Statistical analysis was carried out using a repeated-
measures one-way anova to compare data using SPSS
software. Results from individual hearts acquired dur-
ing pharmacological intervention were compared with
their respective untreated controls using a one-way
anova for correlated samples (SPSS software). A
probability of P < 0.05 was taken as statistically
signiﬁcant. Cross-tabulations with chi-squared or
Fisher’s exact test were used as appropriate for
categorical variables. Data are expressed as
means  standard errors of the mean (SEM). The
numbers, n, denote either numbers of whole hearts or
of peak F/F0 values.
Agents
All drugs and other chemical agents were purchased
from Sigma-Aldrich (Poole, UK) except where other-
wise indicated. FPL-64176 was initially made up with
dimethyl sulfoxide to make a stock concentration of
5.0 mm, and kept wrapped in foil to prevent light
degradation, and was stored at )20  C. Nifedipine was
dissolved in 96% ethanol to make a 1.0 mm stock
concentration, kept wrapped in foil to prevent light
degradation and was kept refrigerated at 4  C. Caf-
feine was dissolved directly in solution A or H as
appropriate and kept at room temperature. CPA was
prepared in 96% ethanol to make a 10 mm stock
concentration, and stored at )20  C. Final drug
concentrations were achieved by dilution with solution
A for electrophysiological experiments and solution H
for experiments in single cells.
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FPL modiﬁes Ca
2+ homeostasis in atrial myocytes
The murine atrial myocytes that were obtained by our
isolation procedure appeared as elongated cells with
rounded but tapered ends with well-deﬁned striations.
They were viable for up to 6–8 h prior to ﬂuorophore
loading. We studied a total of 108 cells from nine hearts
using confocal microscopy following loading with Fluo-
3-AM. These were then subjected to regular pacing
stimuli at a frequency of 1 Hz; higher pacing rates led to
loss of capture in such isolated cells. The resulting
ﬂuorescence signals, F, were expressed normalized to
their baseline values F0. Such values were obtained over
ROIs that covered the entire cell area. In the absence of
added pharmacological agents, this resulted in regular
successions of entrained Ca
2+ transients with stable
amplitudes of mean F/F0 5.36  0.89 (n = 192 peaks
from 16 cells) that decayed to stable baselines with no
evidence of diastolic events (Fig. 1Aa,B; Table 1). Such
Ca
2+ transients would be the result of cycles of
depolarization-induced SR Ca
2+ release into the cytosol
and its subsequent return from cytosol to stores whose
magnitudes and time courses would be sensitive to
manoeuvres affecting either process. The isolated atrial
myocytes thus provided stable preparations in which the
effect of pharmacological agents on the overall magni-
tudes and transients of the resulting Fluo-3 Ca
2+ signals
could be investigated over prolonged periods.
The addition of FPL then resulted in signiﬁcant
disruptions of this regular pattern of Ca
2+ transients.
(A)
a. Control
2 F/F0
1 s
b. FPL 0.1 µM 7 min
(B)
c. FPL 0.1 µM 12 min d. 1.0 µM FPL
**
8
9
NS
3
4
5
6
7
8
0
1
2
3
control 0.1  µM FPL 
< 10 min
0.1 µM FPL 
> 10 min
M
e
a
n
 
p
e
a
k
 
F
/
F
0
Figure 1 Effects of FPL on Ca
2+ transients from regularly stimulated atrial myocytes. (A) Ca
2+ transients obtained in a typical
control myocyte (a) and cells 7 (b) and 12 min following addition of FPL (0.1 lm) (c), and immediately following addition of
1.0 lm FPL (d), showing diastolic transients (b) that eventually disappear (c), and sustained irregular patterns of cytosolic Ca
2+
activity independent of the continued pacing (d). (B) Peak F/F0 values (mean  SEM) obtained from control conditions (clear bar)
and corresponding values obtained <10 min and >10 min following addition of 0.1 lm FPL (ﬁlled bars) (vs. control, NS: no
signiﬁcant difference, **P < 0.01).
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the introduction of low concentrations (0.1 lm) of FPL
(Fig. 1Ab,B). The amplitudes of such evoked Ca
2+
transients then initially remained close to control
values, at 5.14  1.46 (P > 0.05; n = 50 peaks from
four cells). However, at early times (<10 min) following
addition of FPL, there were additional smaller diastolic
Ca
2+ deﬂections that similarly extended over the entire
cell area (Fig. 1Ab). These consisted of frequent, some-
times multiple diastolic peaks (55 diastolic peaks
observed over 50 transients in four of four cells: see
Table 1). However, with continued pacing beyond
10 min these subsidiary peaks disappeared, consistent
with a reduction in available SR Ca upon which such
events might depend. This left a sustained pattern of
large evoked transients with a peak F/F0 of 7.73  0.86
(P < 0.001; n = 50 peaks from four cells) (Fig. 1Ac,B).
Higher FPL concentrations (1.0 lm) initially resulted in
an increased peak F/F0, but this was then often followed
by a loss of the regular pattern of evoked activity. This
was replaced by sustained irregular patterns of cytosolic
Ca
2+ activity that was independent of continued pacing
(Fig. 1Ad, eight cells).
The effects of FPL are modiﬁed by agents known to
modify Ca
2+ homeostasis
The above ﬁndings demonstrated that FPL alters cellu-
lar Ca
2+ homeostasis, consistent with previous reports.
FPL is thought to modify LTCCs through prolonging
their opening during depolarization and their inactiva-
tion upon repolarization, enhancing the duration of the
consequent tail currents (Rampe & Lacerda 1991). The
FPL actions observed here accordingly could take place
entirely through an increased entry of extracellular
Ca
2+, the effect of such an entry on Ca
2+-induced Ca
2+
release (CICR) from the SR Ca
2+ store or both these
effects. These possibilities were investigated using
agents known to modify such Ca
2+ entry, RyR2-
mediated Ca
2+ release or SR Ca
2+ reuptake. The latter
two manoeuvres would be expected to alter SR store
Ca
2+ through separate and therefore independent mech-
anisms.
First, nifedipine was used as a dihydropyridine-LTCC
blocker to diminish extracellular Ca
2+ entry. In the
present experiments on atrial myocytes, nifedipine pre-
treatment lasting 10 min promptly reduced peak F/F0,
to 2.38  0.19 (n = 96 peaks from eight cells) consis-
tent with this known effect in reducing extracellular
Ca
2+ entry (Fig. 2Aa,b). It then abolished the diastolic
Ca
2+ transients produced by a subsequent addition of
0.1 lm FPL (Fig. 2Ac; Table 1). It also abolished the
irregular activity produced by 1.0 lm FPL (Fig. 2Ad)
leaving regular sequences of F/F0 peaks with mean
amplitudes of 3.08  0.70 (n = 117 peaks) (Fig. 2B)
and 3.78  0.83 (n = 78 peaks) (Fig. 2B) respectively.
These observations are consistent with a dependence of
these altered patterns of Ca
2+ homeostasis induced by
Table 1 Occurrence of diastolic calcium release in atrial myocytes
Agents
Number of cells
showing diastolic
release/total
no. of cells
Number of
evoked peaks
examined
Number of
diastolic release
events
Control 0/16 192 0
FPL (0.1 lm) 4/4** 50 55***
FPL (1 lm) 8/8** Sustained irregular
patterns of cytosolic
Ca
2+ activity
Nifedipine 0/8 96 0
CPA pre-treated 20 min 0/16 192 0
Caffeine pre-treated 15 min 0/12 150 0
Nifedipine + 0.1 lm FPL 0/9 117 0
Nifedipine + 1 lm FPL 0/6 78 0
CPA + 0.1 lm FPL<10 min 3/3** 47 46***
CPA + 0.1 lm FPL>10 min 4/11* 143 46***
,§§§
CPA + 1.0 lm FPL 1/3 39 5***
,§§§
Caffeine + 0.1 lm FPL 0/6 78 0
Caffeine + 1 lm FPL 0/6 78 0
CPA, cyclopiazonic acid.
Test agents vs. control ***P < 0.001 on chi-squared testing; test agents vs. control, *P < 0.05, **P < 0.01 on Fisher exact testing;
test agents vs. FPL,
§§§ P <0.001 on chi-squared testing against results obtained with 0.1 lM FPL.
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2+ entry, whether directly through LTCC-
mediated Ca
2+ entry or indirectly through SR-mediated
Ca
2+ release. These latter possibilities were then
resolved using the agents CPA and caffeine, as described
below.
Second, caffeine was used as an agent to increase the
release of intracellularly stored Ca
2+ with a resulting
gradual depletion of SR Ca
2+. The present experiments
in atrial cells demonstrated that a 15 min pre-treatment
with caffeine (1.0 mm) similarly reduced the peak F/F0
of the Ca
2+ transients to 2.75  0.21 (n = 150 peaks
from 12 cells) consistent with such a hypothesis
(Fig. 3Aa,b,B). Such transients showed prolonged kinet-
ics, relative to those shown under control conditions
consistent with our previously reported actions on the
time course of CICR (Zhang et al. 2009). These were
not observed with the remaining pharmacological
interventions. This is illustrated in the full-width half-
maximum values in Table 2. Following such pre-treat-
ment, the addition of FPL (0.1 and 1.0 lm) resulted in a
persistent, regular pattern of stimulation-induced re-
sponses, with reduced amplitudes of 3.04  0.78
(n = 78 peaks from six cells) and 2.89  0.28 (n =7 8
peaks from six cells) (Fig. 3Ac,d,B) respectively but an
absence of diastolic Ca
2+ release. Caffeine pre-treatment
thus rescued the cells from the effects of FPL alone.
Third, CPA was used as a further, independent means
of depleting SR store Ca
2+ through its inhibition of SR
Ca
2+)ATPase activity. In the present experiments, CPA
(0.15 lm) resulted in a progressive reduction of the
amplitude of the evoked transients to a peak F/F0 of
3.64  1.06 (n = 168 peaks). (Fig. 4Aa,b,B; Table 1).
CPA pre-treatment also markedly reduced the incidence
of cells that showed diastolic phenomena following
further addition of 0.1 lm FPL. Thus, of 14 cells
studied, only three cells which were examined at a
period <10 min following addition of 0.1 lm FPL
showed extensive diastolic Ca
2+ release phenomena
(following 46 of 47 examined peaks) (Fig. 4Ac,B;
Table 1). The remaining 11 cells studied >10 min
following addition of FPL showed a lower incidence
of such transients. These followed 46 of 143 peaks and
only occurred in 4 of the 11 cells studied (Fig. 4Ad).
They similarly disappeared >10 min following addition
of FPL, consistent with their dependence upon a limited
Ca store.
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Figure 2 Nifedipine pre-treatment following addition of FPL on Ca
2+ transients from regularly stimulated atrial myocytes. (A) Ca
2+
transients obtained before (a) and immediately following introduction of 0.5 lm nifedipine (b), their partial recovery following the
further addition of 0.1 and 1.0 lm FPL (c, d respectively): none of these records showed diastolic events. (B) Peak F/F0 values
(mean  SEM) obtained under control conditions (clear bar) compared with (vs. control, **P < 0.01; vs. nifedipine ––P < 0.01)
corresponding values obtained following addition of nifedipine (0.5 lm) (second bar from left) and a further addition of FPL (0.1
and 1 lm) (third and fourth bars from left respectively).
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cells that showed an irregular pattern of Ca
2+ activity in
response to the addition of 1.0 lm FPL (Fig. 4Ae). Of
the ﬁve such cells studied, two showed a persistent
irregular pattern but three continued to show a regular
pattern of activity in response to the regular pattern of
stimulation. However, the latter consisted of a series of
Ca
2+ transients that declined to a peak F/F0 of
1.82  0.62 (n = 39 peaks; Fig. 4Af,B) with continued
pacing beyond 10 min (Fig. 4Af,B; Table 1). Only one
cell showed diastolic Ca
2+ release in 5 of 13 peaks even
8–10 min following addition of FPL that nevertheless
disappeared after continued pacing.
Cellular Ca
2+ changes correlate directly with
arrhythmogenic tendencies in intact perfused hearts
The above results directly correlated with ﬁndings
from dual ventricular and atrial bipolar electrogram
(BEG) recordings from Langendorff-perfused hearts
(A)
a. Control b. 1mM caffeine 15 min
2 F/F
1 s
2 F/F0
c. 1mM caffeine + 0.1 µM FPL d. 1mM caffeine + 1 µM FPL
(B)
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** NS
NS
M
e
a
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k
F
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F
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Control Caffeine Caffeine +
0.1 µM FPL
caffeine +
1 µM FPL 
M
Figure 3 Caffeine pre-treatment following addition of FPL on Ca
2+ transients from regularly stimulated atrial myocytes. (A) Ca
2+
transients obtained before (a) and pre-treatment after 15 min following introduction of 1 mm caffeine (b), following introduction
of 0.1 lm FPL (c, d): none of these records showed diastolic events. (B) Peak F/F0 values (mean  SEM) obtained under control
conditions (clear bar) compared with (vs. control **P < 0.01; vs. caffeine NS: no signiﬁcant difference) corresponding values
obtained following addition of caffeine (0.5 lm) (ﬁlled bar) and a further addition of FPL (0.1 and 1 lm) (third and fourth bars
from left respectively).
Table 2 Full-width half-maximum (FWHM) values for Ca
2+
transients obtained from regularly stimulated atrial myocytes
under different conditions
Agents
No. of
peaks
FWHM (ms,
mean  SEM)
Control 12 118  7
0.1 lm FPL 12 117  13
Nifedipine 12 114  21
Caffeine 15 min 12 336  38*
CPA 20 min 12 125  11
Nifedipine + 0.1 lm FPL 12 123  21
Nifedipine + 1.0 lm FPL 12 121  17
Caffeine + 0.1 lm FPL 12 178  15*
Caffeine + 1.0 lm FPL 12 185  8*
CPA + 0.1 lm FPL 12 102  14
CPA + 1.0 lm FPL 12 117  8
CPA, cyclopiazonic acid.
*P < 0.05 when tested against control.
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2+ homeostasis in
atrial arrhythmogenic phenomena. The atrial recordings
in Figs 5 and 6 show both atrial and ventricular
deﬂections whereas atrial deﬂections were absent from
ventricular BEG traces. Atrial pacing at 10 rather than
8 Hz avoided atrial escape phenomena and ensured
regular activation by the stimulus train.
In the absence of test agents, none of the hearts
showed arrhythmic activity, whether in the form of
regular AT or irregular AF, during either intrinsic
activity or regular pacing (Table 3). Three showed AT
lasting 0.5, 1.0 and 5.0 s during PES. However,
addition of FPL (1.0 lm) produced strong arrhythmic
effects in all seven hearts studied. This was accompa-
nied by evidence of third-degree AV block in all seven
cases during intrinsic activity. We observed a total of 12
episodes of sinus pause, in two of seven hearts treated
with FPL as also illustrated in Fig. 5A, with durations in
the range of 0.4–1.6 s. These were not seen in untreated
hearts. Thus, following addition of FPL, three hearts
showed AT lasting 5.6, 5.7 and 14.0 s during intrinsic
activity (Fig. 5A), two showed AT lasting 0.8 and 6.0 s
(Fig. 5B) and two showed AF lasting 2.1 and 5.5 s
respectively during regular pacing. During PES, ﬁve
hearts showed AT lasting 3.8, 7.7, 0.4, 2.0 and 6.8 s
and four showed AF lasting 3.4, 3.1, 0.6 and 18.7 s
respectively (Fig. 5C,D). These arrhythmogenic phe-
nomena took place in an absence of the altered
refractoriness that has been associated with re-entrant
phenomena occurring during atrial arrhythmogenesis
in the experimental system used here. Tissue refracto-
riness has previously been closely associated with the
(A)
a. Control
b. 0.15 µM CPA 20 min
1 s
2 F/F0
c. 0.15 µM CPA + 0.1 µM FPL d. 0.15 µM CPA + 0.1 µM FPL
e. 0.15 µM CPA + 1 µM FPL f. 0.15 µM CPA + 1.0 µM FPL
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Figure 4 Cyclopiazonic acid (CPA) pre-treatment following addition of FPL on Ca
2+ transients from regularly stimulated atrial
myocytes. (A) Results obtained during control conditions (a) and 20 min following the addition of CPA (0.15 lm) (b) and further
introduction of FPL at concentrations of 0.1 lm (c, d) and 1.0 lm (e, f) showing an initial appearance of diastolic signals (c, e)
followed by their disappearance and a decline in the amplitude of the evoked Ca
2+ transients (d, f). (B) Peak F/F0 values (mean 
SEM) obtained before (open bar) and following addition of CPA (0.15 lm) (ﬁlled bar) and a further addition of FPL (vs. control
**P < 0.01; vs. CPA NS: no signiﬁcant difference, ––P < 0.01) (third and fourth bars from left).
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esis in murine hearts (Maguire et al. 2003). We assessed
atrial refractoriness in intact hearts using a decremental
pacing protocol both before and following FPL activa-
tion. The atrial effective refractory period (AERP) was
determined from the shortest S1–S2 interval that failed
to elicit an atrial deﬂection (Thomas et al. 2007). The
addition of FPL (1.0 lm) did not produce signiﬁcant
changes in AERP (control: 22.10  7.80 ms, n =2 2
hearts; FPL: 26.47  6.50 n = 7 hearts; P > 0.05).
Nifedipine, caffeine and CPA treatments reduced
these arrhythmic effects of FPL. Nifedipine pre-treat-
ment combined with a further addition of FPL in six
hearts did not result in arrhythmogenesis during either
intrinsic or regular pacing but ﬁve hearts showed AT
(lasting 1.1, 1.1, 0.3, 2.6 and 29.2 s) during PES
(Fig. 6A). Caffeine pre-treatment abolished FPL-medi-
ated arrhythmic effects during intrinsic, regular pacing
in six hearts. One heart showed AT during PES lasting
5.2 s (Fig. 6B). Finally, with pre-treatment with CPA
combined with a further addition of FPL in ﬁve hearts,
none of the hearts showed arrhythmogenesis during
either intrinsic or regular pacing. During PES two hearts
showed AT (lasting 0.6 and 5.4 s) and two showed
sustained AF both lasting 5.0 s (Fig. 6C).
Discussion
The present study investigated the effect of enhancing
LTCC opening on the initiation of acute atrial arrhyth-
mias at both the cellular and the whole organ levels in
intact murine hearts. We provide an independent
conﬁrmation of the ﬁnding that enhanced extracellular
Ca
2+ entry through using the LTCC agonist FPL exerts
acute atrial arrhythmogenic effects that nevertheless
depend upon diastolic release of intracellularly stored
SR Ca
2+. Thus treatment with FPL resulted in an
appearance both of diastolic Ca
2+ events at the cellular
level, and atrial arrhythmogenesis despite an absence of
changes in AERP at the level of intact perfused hearts.
These phenomena – whether at the cellular or the whole
organ level – were inhibited if the addition of FPL
followed pre-treatment with the LTCC antagonist
nifedipine, suggesting their dependence upon voltage-
activated entry of extracellular Ca
2+. They were also
abolished by pre-treatments with either caffeine or
CPA. This provided two independent methods of
reducing SR Ca
2+. The ﬁrst would increase RyR2-
mediated release of intracellularly stored Ca
2+. The
second would inhibit Ca
2+-ATPase activity. The latter
ﬁndings are consistent with a dependence of the effects
of FPL upon a ﬁnite SR Ca
2+ store. Together these
ﬁndings thus attribute acute atrial arrhythmogenesis
produced by FPL in an otherwise normal heart to an
increased CICR that is dependent upon both Ca entry
and SR Ca
2+.
There have been extensive studies on chronic or
established AF (Yue et al. 1997, Bosch et al. 1999, Van
Wagoner et al. 1999, Skasa et al. 2001, Yagi et al.
2002). Thus, persistent AF has been associated with a
reduction in atrial action potential duration (Li & Nattel
1997). This has been attributed to reductions in current
densities through L-type Ca
2+ channels (ICa,L). Recent
studies have correspondingly shown reduced expression
in mRNA coding for the a1C subunit of L-type channels
in atria from patients with persistent AF (Brundel et al.
1999, Lai et al. 1999). Experimental studies that applied
chronic atrial pacing at rates mimicking AF demon-
strated depressed Ca
2+ currents and numbers of dihy-
dropyridine binding sites (Gaspo et al. 1999). There is
also recent evidence for reduced L-type Ca
2+ currents in
the atrial myocardium of patients with persistent AF
(Bosch et al. 1999, Van Wagoner et al. 1999). These
changes in turn have been implicated in the electrical
remodelling associated with AF (Yue et al. 1997, Bosch
et al. 1999, Van Wagoner et al. 1999, Skasa et al. 2001,
Yagi et al. 2002). These remodelling changes are not
present in patients with non-persistent AF (Skasa et al.
2001). Conversely, AF is accompanied by abnormal SR
Ca
2+ release that likely reﬂects increased open probabil-
ity in hyperphosphorylated RyR2-release channels
(Hulme et al. 2006). In contrast, a recent report
described transgenic (TG) mice with a cardiac over-
expression of junctin and anaccompanying 2.4 fold ICa,L
over-expression. This described the electrophysiological
features of signiﬁcantly lower heart rates in TG
Table 3 Occurrence of arrhythmogenesis (AT or AF) under
different protocols
Agents
Intrinsic
(n)
Regular
pacing
(10 Hz)
(n) PES (n)
Control 0 (36) 0 (36) 3 (36)
FPL 3 (7)** 4 (7)** 7 (7)**
Nifedipine pre-treated 0 (12)* 0 (12)* 3 (12)
##
CPA pre-treated
20 min
0 (11)* 0 (11)* 1 (11)***
Caffeine pre-treated
>15 min
0 (6)* 0 (6)* 0 (6)***
Nifedipine + FPL 0 (6)* 0 (6)* 5 (6)**
CPA + FPL 0 (6)* 0 (6)* 4 (6)**
Caffeine + FPL 0 (6)* 0 (6)* 1 (6)
##
AT, atrial tachycardia; AF, atrial ﬁbrillation; CPA, cyclopiaz-
onic acid; PES, programmed electrical stimulation.
Test agents vs. control P < 0.01**; test agents vs. FPL
P < 0.05*; test agents vs. FPL P < 0.01
## and P < 0.001*** on
Fisher exact testing. Each entry provides both the incidence of
arrhythmogenesis and the number of hearts studied in brackets.
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Figure 5 Examples of atrial arrhythmogenic effects of FPL. Traces of atrial (a) and ventricular (b) bipolar electrogram records
obtained under the following conditions: (A) Spontaneous atrial tachycardia (AT) during intrinsic pacing. (B) AT during regular
pacing. (C, D) AT (C) and atrial ﬁbrillation (AF; D) respectively during programmed electrical stimulation (PES); timing of regular
(S1) and extrasystolic stimulation (S2) indicated below each trace. In the individual traces, ventricular deﬂections are marked ‘V’
and atrial deﬂections are marked ‘A’.
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on examination using limb-lead electrocardiography.
The hearts also showed accompanying ﬁbrotic and
anatomical alterations. However, the precise causal
relationships between these observations were not tested
in detail (Hong et al. 2002).
However, there have been relatively few reports on
factors bearing on the acute initiation of AF in
otherwise structurally normal hearts despite its accepted
clinical importance (see introduction for references).
Previous studies had examined the relationship between
altered Ca
2+ homeostasis at the cellular level (Venetucci
et al. 2007), and acute ventricular arrhythmogenic
tendency in intact hearts (Balasubramaniam et al.
2004, 2005, Goddard et al. 2008). At the cellular level,
the speciﬁc LTCC modulator FPL applied at a concen-
tration of 1.0 lm increases the amplitude of both Ca
2+
currents and Ca
2+ transients more than it increased the
rate of rise of Ca
2+ transients in rat ventricular
myocytes. This would potentially increase the release
AT
A
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b
V
S1 S1 S1 S1 S1 S2 S1 S1 2 S 1 S 1 S 1 S S1 S1
100 ms
(A)
a
A
V
b
V
b
S1 S1 S1 S1 S2 S1 S1 2 S 1 S 1 S 1 S S1 S1
100 ms
V
A (B)
a
V
b
S1 S1 S1 S1 S1 S2 S1 2 S 1 S 1 S 1 S S1 S1
100 ms
Figure 6 Nifedipine, caffeine and cyclopiazonic acid (CPA) pre-treatment abolish FPL-induced arrhythmogenic effects. Traces of
atrial (a) and ventricular (b) bipolar electrogram records obtained during programmed electrical stimulation (PES) (timing of regular
(S1) and extrasystolic stimulation (S2) indicated below each trace) under the following conditions: (A) No atrial tachycardia (AT)
and atrial ﬁbrillation (AF) after nifedipine (0.5 lm). (B) No atrial tachycardia (AT) and atrial ﬁbrillation (AF) after 1 mm caffeine
pre-treatment. (C) A brief AT after CPA (0.15 lm) pre-treatment. In the individual traces, ventricular deﬂections are marked ‘V’ and
atrial deﬂections are marked ‘A’.
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2+ through enhancing
CICR (Fan & Palade 2002). Correspondingly, FPL
produced a Ca
2+-mediated ventricular arrhythmogene-
city at the level of intact Langendorff-perfused murine
hearts. However, these relationships could potentially
differ for atrial arrhythmogenesis. Atrial myocytes show
important differences from ventricular myocytes partic-
ularly in their tubular and SR membrane systems that
might reﬂect functional differences in their Ca
2+
homeostatic processes. They do not possess extensive
T-tubular systems (Mackenzie et al. 2001, 2004) but
instead have prominent transversely oriented SR, Z-
tubular, elements. Instead, atrial cells show an abun-
dant corbular SR containing non-junctional RyR2s
(Jorgensen et al. 1993). Junctional RyR2- ICa,L clusters
are conﬁned to the cell peripheries (Mackenzie et al.
2001). This may reﬂect atrial activation normally
involving CICR in a pattern of centripetal propagation
into the cell interior from superﬁcial T-SR junctions
(Mackenzie et al. 2001, 2004, Bootman et al. 2006).
The present experiments explored for both direct and
indirect effects of an enhanced entry of extracellular
Ca
2+ on both Ca
2+ homeostasis at both the cellular level
and possible arrhythmogenic consequences at the level
of whole hearts. They used the following pharmacolog-
ical agents known to modify Ca
2+ homeostasis: (1) FPL
may modify LTCCs by prolonging channel opening
during depolarization and channel closing upon repo-
larization enhancing the duration of the consequent tail
currents (Rampe & Lacerda 1991) with possible actions
upon SR Ca
2+ release (Katoh et al. 2000, Copello et al.
2007). In rat ventricular myocytes, it increases both
Ca
2+ currents and Ca
2+ transients more than it increases
the rate of rise of Ca
2+ transients, potentially increasing
CICR. (2) Nifedipine is a known competitive dihydro-
pyridine-LTCC blocker in ventricular cells with a KD of
40 nm (Shen et al. 2000, Balasubramaniam et al. 2004,
Thomas et al. 2007). (3) Caffeine increases the release
of intracellularly stored Ca
2+ either by sensitizing
RyR2s to cytosolic Ca
2+ or inhibiting phosphodiesterase
activity, thereby increasing cellular cAMP (Daly 2007),
consequently increasing their open probabilities (Traf-
ford et al. 2000). This would produce a gradual
depletion of SR Ca
2+ as reported previously for
ventricular cells (Gaburjakova & Gaburjakova 2006,
Venetucci et al. 2007). (4) CPA acts through inhibition
of SERCA activity. At 100–200 nm concentrations it
produces a 50% reduction of such activity (Schwinger
et al. 1997) whilst sparing Ca
2+ sensitivity in the
contractile myoﬁlaments (Takahashi et al. 1995), Ca
2+
currents (Bonnet et al. 1994), and Na
+-Ca
2+ exchange
activity (Goeger et al. 1988, Yard et al. 1994).
The experiments demonstrated that the addition of
FPL disrupted the regular pattern of Ca
2+ transients
observed in regularly stimulated isolated Fluo-3-loaded
atrial myocytes studied under confocal microscopy.
These ﬁndings correlated with an appearance of atrial
arrhythmogenesis at the level of intact isolated hearts.
Such effects took place in atria at lower FPL concen-
trations than were needed to produce the corresponding
ventricular effects. These changes occurred despite an
absence of alterations in AERP.
These pro-arrhythmic actions of FPL whether at the
cellular or the whole-heart level were dependent not
only upon entry of extracellular Ca
2+ but also on
availability of releasable SR store Ca
2+. Thus, nifedipine
pre-treatment abolished the changes in Ca
2+ homeosta-
sis produced by a subsequent introduction of FPL at the
level of single cells, on the one hand, and reduced FPL-
induced arrhythmogenesis in whole hearts on the other.
This directly correlates with the known clinical actions
of Ca
2+ channel antagonists in preventing acute post-
operative AF (Podesser et al. 1995, Yilmaz et al. 1996,
Kim et al. 2002, Dobrilovic et al. 2005, Baker & White
2007, Iwamoto & Inoue 2007). It is consistent with the
potential arrhythmogenic effects of extracellular Ca
2+
entry. Pre-treatments with CPA or caffeine would both
be expected to deplete SR Ca
2+ either through an
inhibition of Ca
2+-ATPase activity or an increase in
RyR2-mediated release of intracellularly stored Ca
2+.
These manoeuvres similarly blocked FPL-mediated
alterations in Ca
2+ signalling at the level of isolated
atrial myocytes as well as its arrhythmogenic effects in
intact hearts.
These ﬁndings together are consistent with a model
for the acute atrial arrhythmogenesis in an otherwise
normal heart to a process of CICR, dependent upon
both Ca entry and SR Ca
2+. These would act within a
model for an acute atrial arrhythmogenesis in an
otherwise normal heart that involves triggered activity.
This thus only resulted in transient rather than sustained
arrhythmogenic episodes in an absence of alterations in
the refractory period. The arrhythmogenic phenomena
parallel the diastolic Ca
2+ events produced by FPL
observed at the cellular level. Furthermore, they were
rescued by pharmacological manoeuvres demonstrated
to reduce either SR Ca
2+ or extracellular Ca
2+ entry at
the cellular level. These manoeuvres correspondingly
rescued the diastolic Ca
2+ events at the cellular level
brought about by FPL.
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